{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:17:16Z","timestamp":1787851036729,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023915","name":"Chulalongkorn University Faculty of Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Dental Journal"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.identj.2026.109516","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:17:20Z","timestamp":1774941440000},"page":"109516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Immunophenotypic Profiling and Prognostic Value in Salivary Gland Mucoepidermoid Carcinoma"],"prefix":"10.1016","volume":"76","author":[{"given":"Vy Ngoc Thuy","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komkrit","family":"Ruangritchankul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos G.","family":"Nikitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o N.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-773X","authenticated-orcid":false,"given":"Risa","family":"Chaisuparat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.identj.2026.109516_bib0001","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00000478-200107000-00001","article-title":"Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading","volume":"25","author":"Brandwein","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1601-0825.2002.02870.x","article-title":"Salivary gland tumours","volume":"8","author":"Speight","year":"2002","journal-title":"Oral Dis"},{"key":"10.1016\/j.identj.2026.109516_bib0003","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","article-title":"Systemic therapy in the palliative management of advanced salivary gland cancers","volume":"24","author":"Laurie","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oraloncology.2016.12.016","article-title":"Systemic therapy in metastatic salivary gland carcinomas: a pathology-driven paradigm?","volume":"66","author":"Alfieri","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hed.23256","article-title":"Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients","volume":"36","author":"Chen","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.identj.2026.109516_bib0006","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/his.12488","article-title":"Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading","volume":"65","author":"Katabi","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.identj.2026.109516_bib0007","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0008","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.3390\/cancers14174342","article-title":"Multi-class cancer subtyping in salivary gland carcinomas with MALDI imaging and deep learning","volume":"14","author":"Pertzborn","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.identj.2026.109516_bib0009","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/cancers12113107","article-title":"Molecular and cellular modelling of salivary gland tumors open new landscapes in diagnosis and treatment","volume":"12","author":"Porcheri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.identj.2026.109516_bib0010","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/jcm11030720","article-title":"Targeted therapy, chemotherapy, immunotherapy and novel treatment options for different subtypes of salivary gland cancer","volume":"11","author":"Mueller","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.identj.2026.109516_bib0011","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/jcp-2022-208731","article-title":"Expression, assessment and significance of Ki67 expression in breast cancer: an update","volume":"76","author":"Lashen","year":"2023","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5005\/jp-journals-10024-2269","article-title":"Immunohistochemical detection of proliferative marker Ki-67 in benign and malignant salivary gland tumors","volume":"19","author":"Bussari","year":"2018","journal-title":"J Contemp Dent Pract"},{"key":"10.1016\/j.identj.2026.109516_bib0013","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12253-014-9869-4","article-title":"Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas","volume":"21","author":"Szentk\u00fati","year":"2015","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.identj.2026.109516_bib0014","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.identj.2026.109516_bib0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.identj.2026.109516_bib0016","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1038\/s41598-023-31055-3","article-title":"Systematic review of NTRK 1\/2\/3 fusion prevalence pan-cancer and across solid tumours","volume":"13","author":"O\u2019Haire","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.identj.2026.109516_bib0017","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1093\/oncolo\/oyac080","article-title":"Larotrectinib treatment for patients with TRK fusion-positive salivary gland cancers","volume":"29","author":"Le","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.identj.2026.109516_bib0018","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of Larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.identj.2026.109516_bib0019","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0020","unstructured":"Food and Drug Administration Website. Approved drug products with therapeutic equivalence evaluations 2021 Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/approved-drug-products-therapeutic-equivalence-evaluations-orange-book. Accessed 26 October 2021."},{"key":"10.1016\/j.identj.2026.109516_bib0021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-021-00206-y","article-title":"Genomic context of NTRK1\/2\/3 fusion-positive tumours from a large real-world population","volume":"5","author":"Westphalen","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00183","article-title":"Analysis of NTRK alterations in pan-cancer adult and pediatric malignancies: implications for NTRK-targeted therapeutics","volume":"2","author":"Okamura","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0024","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/odi.15216","article-title":"Immunoarchitectural pattern and its potential prognostic value in mucoepidermoid carcinoma","volume":"31","author":"Tran","year":"2024","journal-title":"Oral Dis"},{"key":"10.1016\/j.identj.2026.109516_bib0025","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3174\/ajnr.A7960","article-title":"Update from the 5th edition of the WHO classification of nasal, paranasal, and skull base tumors: imaging overview with histopathologic and genetic correlation","volume":"44","author":"Agarwal","year":"2023","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.identj.2026.109516_bib0026","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/003655402_000028047","article-title":"Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes","volume":"122","author":"Brandwein","year":"2002","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.identj.2026.109516_bib0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.identj.2026.109516_bib0029","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pathol.2016.11.006","article-title":"Ki67 assessment in breast cancer: an update","volume":"49","author":"Penault-Llorca","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.identj.2026.109516_bib0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/his.13007","article-title":"Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours","volume":"69","author":"Focke","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.identj.2026.109516_bib0031","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00428-020-02921-6","article-title":"Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial","volume":"478","author":"De Winne","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.identj.2026.109516_bib0032","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0033","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/ijms21041287","article-title":"Aquaporin 1, 3, and 5 patterns in salivary gland mucoepidermoid carcinoma: expression in surgical specimens and an in vitro pilot study","volume":"21","author":"Stamboni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.identj.2026.109516_bib0034","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12105-008-0074-1","article-title":"Comparative cytokeratin expression in the different cell types of salivary gland mucoepidermoid carcinoma","volume":"2","author":"Azevedo","year":"2008","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4274\/MMJ.galenos.2022.63139","article-title":"Heterogeneity of genetic landscapes in salivary gland tumors and their critical roles in current management","volume":"37","author":"Yousaf","year":"2022","journal-title":"Medeni Med J"},{"key":"10.1016\/j.identj.2026.109516_bib0036","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/cells10113068","article-title":"Heterogeneity of cancer stem cells in tumorigenesis, metastasis, and resistance to antineoplastic treatment of head and neck tumours","volume":"10","author":"Cirillo","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.identj.2026.109516_bib0037","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/biomedicines11020519","article-title":"Molecular targets in salivary gland cancers: a comprehensive genomic analysis of 118 mucoepidermoid carcinoma tumors","volume":"11","author":"Bou Zerdan","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.identj.2026.109516_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101496","article-title":"Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma","volume":"24","author":"Kang","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0039","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/modpathol.3880426","article-title":"Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland","volume":"14","author":"Okabe","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0714.2007.00631.x","article-title":"Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours","volume":"37","author":"Vargas","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.identj.2026.109516_bib0041","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1601-0825.2005.01166.x","article-title":"Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature","volume":"12","author":"Triantafillidou","year":"2006","journal-title":"Oral Dis"},{"key":"10.1016\/j.identj.2026.109516_bib0042","first-page":"1429","article-title":"Ki-67 and p53 immunostaining assessment of proliferative activity in salivary tumors","volume":"56","author":"Faur","year":"2015","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.identj.2026.109516_bib0043","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.joms.2009.03.021","article-title":"Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases","volume":"67","author":"Miyabe","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.identj.2026.109516_bib0044","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12022-025-09880-1","article-title":"Intratumoral heterogeneity of Ki67 index and its impact on the diagnosis and prognostication of pancreatic neuroendocrine tumors: hot-spot count differs significantly from random-area count","volume":"36","author":"Eren","year":"2025","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119565","article-title":"Evaluation of an optimal cut-off point for the Ki-67 index as a prognostic factor in primary breast cancer: a retrospective study","volume":"10","author":"Tashima","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.identj.2026.109516_bib0046","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12876-024-03417-2","article-title":"Prognostic implications of CK19 positivity in patients with early recurrent hepatocellular carcinoma after hepatic resection undergoing transarterial chemoembolization","volume":"24","author":"Zhu","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.identj.2026.109516_bib0047","doi-asserted-by":"crossref","first-page":"21425","DOI":"10.1002\/jcp.28768","article-title":"Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods","volume":"234","author":"Mehrpouya","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.identj.2026.109516_bib0048","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s12032-013-0636-2","article-title":"Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis","volume":"30","author":"Liu","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0049","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.humpath.2010.07.022","article-title":"Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential","volume":"42","author":"Machida","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/jop.13488","article-title":"Identifying potential immuno-oncology targets in salivary gland mucoepidermoid carcinoma based on inflammatory status and treatment response","volume":"52","author":"Urumarudappa","year":"2023","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.identj.2026.109516_bib0051","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12105-023-01528-y","article-title":"Prognostic impact of tumor immune microenvironment and its predictive role in salivary gland cancer","volume":"17","author":"Veneroni","year":"2023","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0052","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.identj.2026.109516_bib0053","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.13981","article-title":"Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion","volume":"76","author":"Xu","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.identj.2026.109516_bib0054","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/his.13666","article-title":"Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics","volume":"73","author":"Hung","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.identj.2026.109516_bib0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejca.2022.06.030","article-title":"The sensitivity of pan-TRK immunohistochemistry in solid tumours: a meta-analysis","volume":"173","author":"Hondelink","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.identj.2026.109516_bib0056","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/his.14884","article-title":"A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types","volume":"82","author":"Haberecker","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.identj.2026.109516_bib0057","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchio","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.identj.2026.109516_bib0058","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/PAI.0000000000000360","article-title":"Detecting gene rearrangements in patient populations through a 2-step diagnostic test comprised of rapid IHC enrichment followed by sensitive next-generation sequencing","volume":"25","author":"Murphy","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["International Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:20:09Z","timestamp":1787847609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020653926001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0020653926001103"],"URL":"https:\/\/doi.org\/10.1016\/j.identj.2026.109516","relation":{},"ISSN":["0020-6539"],"issn-type":[{"value":"0020-6539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Immunophenotypic Profiling and Prognostic Value in Salivary Gland Mucoepidermoid Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Dental Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.identj.2026.109516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of FDI World Dental Federation.","name":"copyright","label":"Copyright"}],"article-number":"109516"}}